3 completed, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
Follow GW 876008: new trials by email Literature Review of GW 876008 trials Research Report on GW 876008
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679 GW876008 and GSK561679 - Irritable Bowel Syndrome | Phase 2 | Withdrawn | GlaxoSmithKline | 2007-08-01 | 2015-03-02 | |
| Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome GW876008 - Irritable Colon | Phase 2 | Completed | GlaxoSmithKline | 10 | 2006-12-08 | 2017-08-08 |
| Treatment Of Patients With Social Anxiety Disorder GW876008, paroxetine - Social Phobia | Phase 2 | Completed | GlaxoSmithKline | 299 | 2006-11-09 | 2017-07-11 |
| Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome GW876008, Placebo - Irritable Bowel Syndrome (IBS) | Phase 2 | Completed | GlaxoSmithKline | 133 | 2006-10-14 | 2018-01-31 |
Irritable Bowel Syndrome (3) · Phobia, Social (1)
GlaxoSmithKline (4)
Canada (2) · United States (2) · Finland (1) · Germany (1) · Norway (1) · South Africa (1) · Sweden (1) · United Kingdom (1)